Method for treating joint pain and associated instruments

US9730744B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9730744-B2
Application numberUS-201615166345-A
CountryUS
Kind codeB2
Filing dateMay 27, 2016
Priority dateNov 20, 2009
Publication dateAug 15, 2017
Grant dateAug 15, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The embodiments provide provides devices, instruments, and associated methods for treating joint pain. A joint is evaluated using magnetic resonance imaging to detect any defects in the subchondral bone. For example, using T2-weighted MRI images, bone marrow lesions or edemas can be identified, and using T1-weighted MRI images, associated regions of sclerotic bone adjacent to the bone marrow lesion can be identified. The treatment method may involve introducing a bone void filler material at the site to address the bone marrow lesion or edema, and/or drilling and inserting an implant to address the sclerotic bone, bone marrow lesion or edema, and insufficiency or stress fractures. An access path is mapped to a location in the subchondral region where the insufficiency fracture resides. The access path attempts to preserve an articular surface of the joint. A reinforcing member that stabilizes the insufficiency fracture is then implanted via the access path.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of accessing a targeted delivery site in a subchondral region of a proximal tibia, the method comprising: identifying a subchondral defect in a subchondral region of a proximal tibia, the subchondral region occurring under an articular surface of the proximal tibia; providing a guide instrument positioned adjacent the proximal tibia with a tip of a probe of the guide instrument contacting a location on the articular surface of the proximal tibia and with a first opening in the guide instrument being in receipt of an access tool that is advanceable through the first opening for entry into the proximal tibia, wherein the tip of the probe contacting said location establishes a targeted delivery site in the subchondral region of the proximal tibia in and/or adjacent to the subchondral defect, the targeted delivery site spaced a distance from the tip of the probe; and advancing the access tool through the first opening and into the proximal tibia, wherein the first opening guides the access tool to the targeted delivery site in a first direction and in a manner that preserves an existing condition of the articular surface of the proximal tibia. 2. The method of claim 1 , further comprising injecting an injectable material into the targeted delivery site. 3. The method of claim 2 , wherein the injectable material includes an injectable calcium phosphate. 4. The method of claim 3 , wherein the subchondral defect includes a bone marrow lesion. 5. The method of claim 4 , wherein the targeted delivery site is adjacent to the bone marrow lesion. 6. The method of claim 1 , wherein the targeted delivery site is within 5 mm from the tip of the probe. 7. The method of claim 1 , wherein said first direction is parallel to the articular surface of the proximal tibia. 8. The method of claim 1 , wherein said first direction is parallel to a direction of travel of the reference probe. 9. The method of claim 1 , wherein the guide instrument includes a second opening therein for guiding said access tool or a second access tool to the targeted delivery site in a second direction and in a manner that preserves the existing condition of the articular surface of the proximal tibia, said second direction angled acutely relative to said first direction. 10. The method of claim 9 further comprising advancing the access tool or the second access tool in said second direction through the second opening to the targeted delivery site in a manner that preserves the existing condition of the articular surface of the proximal tibia. 11. The method of claim 1 , wherein the subchondral defect includes an insufficiency fracture. 12. A method of accessing a targeted delivery site in a subchondral region of a proximal tibia, the method comprising: identifying a bone marrow lesion in a subchondral region of a proximal tibia, the subchondral region occurring under an articular surface of the proximal tibia; providing a guide instrument positioned adjacent the proximal tibia with a tip of a probe of the guide instrument contacting a location on the articular surface of the proximal tibia and with a first opening in the guide instrument being in receipt of an access tool that is advanceable through the first opening for entry into the proximal tibia, wherein the tip of the probe contacting said location establishes a targeted delivery site in the subchondral region of the proximal tibia in and/or adjacent to the bone marrow lesion, the targeted delivery site spaced a distance from the tip of the probe; and advancing the access tool through the first opening and into the proximal tibia, wherein the first opening guides the access tool to the targeted delivery site in a first direction and in a manner that preserves an existing condition of the articular surface of the proximal tibia. 13. The method of claim 12 , further comprising injecting an injectable fluid material into the targeted delivery site. 14. The method of claim 13 , wherein the injectable fluid material is left in the targeted delivery site for becoming less fluid in the targeted delivery site for reinforcing bone located in the bone marrow lesion. 15. The method of claim 12 , further comprising injecting an injectable calcium phosphate material into the targeted delivery site. 16. The method of claim 12 , wherein the targeted delivery site is adjacent to the bone marrow lesion. 17. The method of claim 12 , wherein the targeted delivery site is within 5 mm from the tip of the probe. 18. The method of claim 12 , wherein said first direction is parallel to the articular surface of the proximal tibia. 19. The method of claim 12 , wherein said first direction is parallel to a direction of travel of the reference probe. 20. The method of claim 12 , wherein the guide instrument includes a second opening therein for guiding said access tool or a second access tool to the targeted delivery site in a second direction and in a manner that preserves the existing condition of the articular surface of the proximal tibia, said second direction angled acutely relative to said first direction. 21. The method of claim 20 further comprising advancing the access tool or the second access tool in said second direction through the second opening to the targeted delivery site in a manner that preserves the existing condition of the articular surface of the proximal tibia.

Assignees

Inventors

Classifications

  • for the foot or ankle · CPC title

  • for introducing fluid filler into bone or extracting it (A61B17/7097, A61B17/8833 take precedence) · CPC title

  • for elbows or knees · CPC title

  • Joints · CPC title

  • Equipment for handling bone cement or other fluid fillers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9730744B2 cover?
The embodiments provide provides devices, instruments, and associated methods for treating joint pain. A joint is evaluated using magnetic resonance imaging to detect any defects in the subchondral bone. For example, using T2-weighted MRI images, bone marrow lesions or edemas can be identified, and using T1-weighted MRI images, associated regions of sclerotic bone adjacent to the bone marrow le…
Who is the assignee on this patent?
Zimmer Knee Creations Inc
What technology area does this patent fall under?
Primary CPC classification A61B17/8805. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).